| Year |
Citation |
Score |
| 2020 |
Miles BCH, Shpitser I, Kanki P, Meloni S, Tchetgen EJT. On semiparametric estimation of a path-specific effect in the presence of mediator-outcome confounding. Biometrika. 107: 159-172. PMID 33390591 DOI: 10.1093/Biomet/Asz063 |
0.537 |
|
| 2020 |
Ogbenna AA, Meloni S, Inzaule S, Hamers RL, Sigaloff K, Osibogun A, Adeyemo TA, Okonkwo P, Samuels JO, Kanki PJ, Rinke de Wit TF, Akanmu AS. The impact of HIV-1 subtypes on virologic and immunologic treatment outcomes at the Lagos University Teaching Hospital: A longitudinal evaluation. Plos One. 15: e0238027. PMID 32841264 DOI: 10.1371/Journal.Pone.0238027 |
0.665 |
|
| 2020 |
Meloni ST, Agaba P, Chang CA, Yiltok E, Oguche S, Ejeliogu E, Agbaji O, Okonkwo P, Kanki PJ. Longitudinal evaluation of adherence, retention, and transition patterns of adolescents living with HIV in Nigeria. Plos One. 15: e0236801. PMID 32735566 DOI: 10.1371/Journal.Pone.0236801 |
0.652 |
|
| 2020 |
Onwuamah CK, Okpokwu J, Audu R, Imade G, Meloni ST, Okwuraiwe A, Chebu P, Musa AZ, Chaplin B, Dalhatu I, Agbaji O, Samuels J, Ezechi O, Ahmed M, Odaibo G, et al. Low levels of HIV-1 drug resistance mutations in patients who achieved viral re-suppression without regimen switch: a retrospective study. Bmc Microbiology. 20: 17. PMID 31959116 DOI: 10.1186/S12866-020-1706-1 |
0.664 |
|
| 2019 |
Balogun M, Meloni ST, Igwilo UU, Roberts A, Okafor I, Sekoni A, Ogunsola F, Kanki PJ, Akanmu S. Status of HIV-infected patients classified as lost to follow up from a large antiretroviral program in southwest Nigeria. Plos One. 14: e0219903. PMID 31344057 DOI: 10.1371/Journal.Pone.0219903 |
0.684 |
|
| 2019 |
Balogun MR, Sekoni AO, Meloni ST, Odukoya OO, Onajole AT, Longe-Peters OA, Ogunsola FT, Kanki PJ. Predictors of tuberculosis knowledge, attitudes and practices in urban slums in Nigeria: a cross-sectional study. The Pan African Medical Journal. 32: 60. PMID 31223352 DOI: 10.11604/Pamj.2019.32.60.14622 |
0.503 |
|
| 2019 |
Meloni ST, Agbaji O, Chang CA, Agaba P, Imade G, Oguche S, Mukhtar A, Mitruka K, Cox MH, Zee A, Kanki P. The role of point-of-care viral load monitoring in achieving the target of 90% suppression in HIV-infected patients in Nigeria: study protocol for a randomized controlled trial. Bmc Infectious Diseases. 19: 368. PMID 31046695 DOI: 10.1186/S12879-019-3983-6 |
0.604 |
|
| 2018 |
Agaba PA, Genberg BL, Sagay AS, Agbaji OO, Meloni ST, Dadem NY, Kolawole GO, Okonkwo P, Kanki PJ, Ware NC. Retention in Differentiated Care: Multiple Measures Analysis for a Decentralized HIV Care and Treatment Program in North Central Nigeria. Journal of Aids & Clinical Research. 9. PMID 29682399 DOI: 10.4172/2155-6113.1000756 |
0.682 |
|
| 2017 |
Miles CH, Shpitser I, Kanki P, Meloni S, Tchetgen EJT. Quantifying an Adherence Path-Specific Effect of Antiretroviral Therapy in the Nigeria PEPFAR Program. Journal of the American Statistical Association. 112: 1443-1452. PMID 32042214 DOI: 10.1080/01621459.2017.1295862 |
0.623 |
|
| 2017 |
Agaba PA, Meloni ST, Sule HM, Agbaji OO, Sagay AS, Okonkwo P, Idoko JA, Kanki PJ. Treatment Outcomes Among Older Human Immunodeficiency Virus-Infected Adults in Nigeria. Open Forum Infectious Diseases. 4: ofx031. PMID 29497627 DOI: 10.1093/Ofid/Ofx031 |
0.553 |
|
| 2017 |
Meloni ST, Onwuamah CK, Agbaji O, Chaplin B, Olaleye DO, Audu R, Samuels J, Ezechi O, Imade G, Musa AZ, Odaibo G, Okpokwu J, Rawizza H, Mu'azu MA, Dalhatu I, et al. Implication of First-Line Antiretroviral Therapy Choice on Second-Line Options. Open Forum Infectious Diseases. 4: ofx233. PMID 29255731 DOI: 10.1093/Ofid/Ofx233 |
0.568 |
|
| 2017 |
Chaplin B, Imade GE, Onwuamah C, Odaibo G, Audu R, Okpokwu J, Olaleye DO, Meloni S, Rawizza H, Muazu M, Musa AZ, Samuels J, Agbaji O, Ezechi O, Idigbe E, et al. Distinct pattern of TAMs with K65R in patients failing tenofovir-based antiretroviral therapy. Aids Research and Human Retroviruses. PMID 29084434 DOI: 10.1089/Aid.2017.0198 |
0.635 |
|
| 2017 |
Meloni ST, Chaplin B, Idoko J, Agbaji O, Akanmu S, Imade G, Okonkwo P, Murphy RL, Kanki PJ. Drug resistance patterns following pharmacy stock shortage in Nigerian Antiretroviral Treatment Program. Aids Research and Therapy. 14: 58. PMID 29029637 DOI: 10.1186/S12981-017-0184-5 |
0.569 |
|
| 2017 |
Agaba P, Meloni S, Sule H, Ocheke A, Agaba E, Idoko J, Kanki P. Factors associated with early menopause among women in Nigeria. Journal of Virus Eradication. 3: 145-151. PMID 28758022 DOI: 10.1016/S2055-6640(20)30333-2 |
0.71 |
|
| 2017 |
Agaba PA, Meloni ST, Sule HM, Ocheke AN, Agaba EI, Idoko JA, Kanki PJ. Prevalence and predictors of severe menopause symptoms among HIV-positive and -negative Nigerian women. International Journal of Std & Aids. 956462417704778. PMID 28409538 DOI: 10.1177/0956462417704778 |
0.638 |
|
| 2017 |
Agaba PA, Meloni ST, Sule HM, Agaba EI, Idoko JA, Kanki PJ. Sexual dysfunction and its determinants among women infected with HIV. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. PMID 28273350 DOI: 10.1002/Ijgo.12140 |
0.637 |
|
| 2017 |
Miles C, Kanki P, Meloni S, Tchetgen Tchetgen E. On Partial Identification of the Natural Indirect Effect Journal of Causal Inference. 5. DOI: 10.1515/jci-2016-0004 |
0.454 |
|
| 2016 |
Meloni ST, Chang CA, Eisen G, Jolayemi T, Banigbe B, Okonkwo PI, Kanki PJ. Long-Term Outcomes on Antiretroviral Therapy in a Large Scale-Up Program in Nigeria. Plos One. 11: e0164030. PMID 27764094 DOI: 10.1371/Journal.Pone.0164030 |
0.548 |
|
| 2016 |
Scarsi KK, Eisen G, Darin KM, Meloni ST, Rawizza HE, Tchetgen Tchetgen EJ, Agbaji OO, Onwujekwe DI, Gashau W, Nkado R, Okonkwo P, Murphy RL, Kanki PJ. Superior Effectiveness of Zidovudine Compared With Tenofovir When Combined With Nevirapine-based Antiretroviral Therapy in a Large Nigerian Cohort. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 62: 512-8. PMID 26561532 DOI: 10.1093/Cid/Civ928 |
0.559 |
|
| 2015 |
Hamel DJ, Sankalé JL, Samuels JO, Sarr AD, Chaplin B, Ofuche E, Meloni ST, Okonkwo P, Kanki PJ. Building laboratory capacity to support HIV care in Nigeria: Harvard/APIN PEPFAR, 2004-2012. African Journal of Laboratory Medicine. 4. PMID 26900573 DOI: 10.4102/Ajlm.V4I1.190 |
0.664 |
|
| 2015 |
Chang CA, Meloni ST, Eisen G, Chaplin B, Akande P, Okonkwo P, Rawizza HE, Tchetgen Tchetgen E, Kanki PJ. Tuberculosis Incidence and Risk Factors Among Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy in a Large HIV Program in Nigeria. Open Forum Infectious Diseases. 2: ofv154. PMID 26613097 DOI: 10.1093/Ofid/Ofv154 |
0.658 |
|
| 2015 |
Meloni ST, Chaplin B, Chang C, Rawizza H, Okonkwo P, Kanki PJ. Patterns of Adherence and Loss to Follow-Up in Pediatric Patients on ART in Nigeria. Current Hiv Research. 13: 210-8. PMID 25986372 DOI: 10.2174/1570162X1303150506183921 |
0.636 |
|
| 2015 |
Rawizza HE, Chang CA, Chaplin B, Ahmed IA, Meloni ST, Oyebode T, Banigbe B, Sagay AS, Adewole IF, Okonkwo P, Kanki PJ, The Apin Pepfar Team EY. Loss to Follow-Up within the Prevention of Mother-to-Child Transmission Care Cascade in a Large ART Program in Nigeria. Current Hiv Research. 13: 201-209. PMID 25986371 DOI: 10.2174/1570162X1303150506183256 |
0.632 |
|
| 2015 |
Sagay AS, Ebonyi AO, Meloni ST, Musa J, Oguche S, Ekwempu CC, Oyebode T, Ejeliogu E, Imade GE, Agbaji OO, Okonkwo P, Kanki PJ. Mother-to-Child Transmission Outcomes of HIV-Exposed Infants Followed Up in Jos North-Central Nigeria. Current Hiv Research. 13: 193-200. PMID 25986370 DOI: 10.2174/1570162X1303150506182534 |
0.658 |
|
| 2015 |
Balogun M, Sekoni A, Meloni ST, Odukoya O, Onajole A, Longe-Peters O, Ogunsola F, Kanki PJ. Trained community volunteers improve tuberculosis knowledge and attitudes among adults in a periurban community in southwest Nigeria. The American Journal of Tropical Medicine and Hygiene. 92: 625-32. PMID 25510722 DOI: 10.4269/Ajtmh.14-0527 |
0.5 |
|
| 2015 |
Chaplin B, Meloni S, Eisen G, Jolayemi T, Banigbe B, Adeola J, Wen C, Reyes Nieva H, Chang C, Okonkwo P, Kanki P. Scale-up of networked HIV treatment in Nigeria: creation of an integrated electronic medical records system. International Journal of Medical Informatics. 84: 58-68. PMID 25301692 DOI: 10.1016/J.Ijmedinf.2014.09.006 |
0.631 |
|
| 2014 |
Ebonyi AO, Oguche S, Meloni ST, Sagay SA, Kyriacou DN, Achenbach CJ, Agbaji OO, Oyebode TA, Okonkwo P, Idoko JA, Kanki PJ. Predictors of Mortality in a Clinic Cohort of HIV-1 Infected Children Initiated on Antiretroviral Therapy in Jos, Nigeria. Journal of Aids & Clinical Research. 5. PMID 30416842 DOI: 10.4172/2155-6113.1000403 |
0.68 |
|
| 2014 |
Meloni ST, Chang C, Chaplin B, Rawizza H, Jolayemi O, Banigbe B, Okonkwo P, Kanki P. Time-Dependent Predictors of Loss to Follow-Up in a Large HIV Treatment Cohort in Nigeria. Open Forum Infectious Diseases. 1: ofu055. PMID 25734125 DOI: 10.1093/Ofid/Ofu055 |
0.633 |
|
| 2014 |
Olaleye DO, Odaibo GN, Carney P, Agbaji O, Sagay AS, Muktar H, Akinyinka OO, Omigbodun AO, Ogunniyi A, Gashau W, Akanmu S, Ogunsola F, Chukwuka C, Okonkwo PI, Meloni ST, et al. Enhancement of health research capacity in Nigeria through north-south and in-country partnerships. Academic Medicine : Journal of the Association of American Medical Colleges. 89: S93-7. PMID 25072590 DOI: 10.1097/Acm.0000000000000353 |
0.491 |
|
| 2014 |
Agaba PA, Meloni ST, Sule HM, Agbaji OO, Ekeh PN, Job GC, Nyango N, Ugoagwu PO, Imade GE, Idoko JA, Kanki PJ. Patients who present late to HIV care and associated risk factors in Nigeria. Hiv Medicine. 15: 396-405. PMID 24580742 DOI: 10.1111/Hiv.12125 |
0.657 |
|
| 2014 |
Imade GE, Sagay AS, Chaplin B, Chebu P, Musa J, Okpokwu J, Hamel DJ, Pam IC, Agbaji O, Samuels J, Meloni S, Sankale JL, Okonkwo P, Kanki P. Short communication: Transmitted HIV drug resistance in antiretroviral-naive pregnant women in north central Nigeria. Aids Research and Human Retroviruses. 30: 127-33. PMID 24164431 DOI: 10.1089/Aid.2013.0074 |
0.7 |
|
| 2013 |
Imade GE, Sagay AS, Musa J, Ocheke AN, Adeniyi DS, Idighri M, Powl R, Sendeht A, Ogwuche JP, Elujoba M, Egbodo CO, Oyebode T, Daru PH, Agbaji O, Pam IC, ... Meloni ST, et al. Declining rate of infection with maternal human immunodeficiency virus at delivery units in north-central Nigeria. African Journal of Reproductive Health. 17: 138-45. PMID 24689325 |
0.678 |
|
| 2013 |
Rawizza HE, Chaplin B, Meloni ST, Darin KM, Olaitan O, Scarsi KK, Onwuamah CK, Audu RA, Chebu PR, Imade GE, Okonkwo P, Kanki PJ. Accumulation of protease mutations among patients failing second-line antiretroviral therapy and response to salvage therapy in Nigeria. Plos One. 8: e73582. PMID 24069209 DOI: 10.1371/Journal.Pone.0073582 |
0.558 |
|
| 2013 |
Dinic L, Idigbe OE, Meloni S, Rawizza H, Akande P, Eisen G, Onwujekwe D, Agbaji O, Ani A, Kanki PJ. Sputum smear concentration may misidentify acid-fast bacilli as Mycobacterium tuberculosis in HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes (1999). 63: 168-77. PMID 23392466 DOI: 10.1097/Qai.0B013E31828983B9 |
0.768 |
|
| 2013 |
Agbaji O, Thio CL, Meloni S, Graham C, Muazu M, Nimzing L, Idoko J, Sankalé JL, Ekong E, Murphy R, Kanki P, Hawkins C. Impact of hepatitis C virus on HIV response to antiretroviral therapy in Nigeria. Journal of Acquired Immune Deficiency Syndromes (1999). 62: 204-7. PMID 23196830 DOI: 10.1097/Qai.0B013E31827Ce536 |
0.655 |
|
| 2013 |
Agbaji O, Ebonyi AO, Meloni ST, Anejo-Okopi JA, Akanbi MO, Oguche S, Agaba PA, Sagay AS, Okonkwo P, Kanki P. Factors associated with pulmonary tuberculosis-HIV co-infection in Treatment-Naive Adults in Jos, North Central Nigeria Journal of Aids and Clinical Research. 4. DOI: 10.4172/2155-6113.1000222 |
0.7 |
|
| 2011 |
Rawizza HE, Chaplin B, Meloni ST, Eisen G, Rao T, Sankalé JL, Dieng-Sarr A, Agbaji O, Onwujekwe DI, Gashau W, Nkado R, Ekong E, Okonkwo P, Murphy RL, Kanki PJ, et al. Immunologic criteria are poor predictors of virologic outcome: implications for HIV treatment monitoring in resource-limited settings. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 53: 1283-90. PMID 22080121 DOI: 10.1093/Cid/Cir729 |
0.597 |
|
| 2011 |
Chaplin B, Eisen G, Idoko J, Onwujekwe D, Idigbe E, Adewole I, Gashau W, Meloni S, Sarr AD, Sankalé JL, Ekong E, Murphy RL, Kanki P. Impact of HIV type 1 subtype on drug resistance mutations in Nigerian patients failing first-line therapy Aids Research and Human Retroviruses. 27: 71-80. PMID 20964479 DOI: 10.1089/Aid.2010.0050 |
0.624 |
|
| 2010 |
Taiwo B, Chaplin B, Penugonda S, Meloni S, Akanmu S, Gashau W, Idoko J, Adewole I, Murphy R, Kanki P. Suboptimal etravirine activity is common during failure of nevirapine-based combination antiretroviral therapy in a cohort infected with non-B subtype HIV-1. Current Hiv Research. 8: 194-8. PMID 20163340 DOI: 10.2174/157016210791111098 |
0.654 |
|
| 2009 |
Idoko J, Meloni S, Muazu M, Nimzing L, Badung B, Hawkins C, Sankalé JL, Ekong E, Murphy R, Kanki P, Thio CL. Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 49: 1268-73. PMID 19772386 DOI: 10.1086/605675 |
0.702 |
|
| 2007 |
Hamel DJ, Sankalé JL, Eisen G, Meloni ST, Mullins C, Gueye-Ndiaye A, Mboup S, Kanki PJ. Twenty years of prospective molecular epidemiology in Senegal: changes in HIV diversity. Aids Research and Human Retroviruses. 23: 1189-96. PMID 17961103 DOI: 10.1089/Aid.2007.0037 |
0.714 |
|
| 2007 |
Sankalé JL, Langevin S, Odaibo G, Meloni ST, Ojesina AI, Olaleye D, Kanki P. The complexity of circulating HIV type 1 strains in Oyo state, Nigeria. Aids Research and Human Retroviruses. 23: 1020-5. PMID 17725419 DOI: 10.1089/Aid.2006.0304 |
0.75 |
|
| 2007 |
MacNeil A, Sarr AD, Sankalé JL, Meloni ST, Mboup S, Kanki P. Direct evidence of lower viral replication rates in vivo in human immunodeficiency virus type 2 (HIV-2) infection than in HIV-1 infection. Journal of Virology. 81: 5325-30. PMID 17329334 DOI: 10.1128/Jvi.02625-06 |
0.712 |
|
| 2007 |
MacNeil A, Sankale JL, Meloni ST, Sarr AD, Mboup S, Kanki P. Long-term intrapatient viral evolution during HIV-2 infection. The Journal of Infectious Diseases. 195: 726-33. PMID 17262716 DOI: 10.1086/511308 |
0.715 |
|
| 2006 |
Ojesina AI, Sankalé JL, Odaibo G, Langevin S, Meloni ST, Sarr AD, Olaleye D, Kanki PJ. Subtype-specific patterns in HIV Type 1 reverse transcriptase and protease in Oyo State, Nigeria: implications for drug resistance and host response. Aids Research and Human Retroviruses. 22: 770-9. PMID 16910833 DOI: 10.1089/Aid.2006.22.770 |
0.781 |
|
| 2006 |
MacNeil A, Sankalé JL, Meloni ST, Sarr AD, Mboup S, Kanki P. Genomic sites of human immunodeficiency virus type 2 (HIV-2) integration: similarities to HIV-1 in vitro and possible differences in vivo. Journal of Virology. 80: 7316-21. PMID 16840312 DOI: 10.1128/Jvi.00604-06 |
0.705 |
|
| 2006 |
MacNeil A, Sankalé J, Meloni ST, Sarr AD, Mboup S, Kanki P. Long-term intrapatient evolution during HIV-2 infection Retrovirology. 3. DOI: 10.1186/1742-4690-3-S1-P38 |
0.717 |
|
| 2004 |
Meloni ST, Sankalé JL, Hamel DJ, Eisen G, Guéye-Ndiaye A, Mboup S, Kanki PJ. Molecular epidemiology of human immunodeficiency virus type 1 sub-subtype A3 in Senegal from 1988 to 2001. Journal of Virology. 78: 12455-61. PMID 15507632 DOI: 10.1128/Jvi.78.22.12455-12461.2004 |
0.676 |
|
| 2004 |
Meloni ST, Kim B, Sankalé JL, Hamel DJ, Tovanabutra S, Mboup S, McCutchan FE, Kanki PJ. Distinct human immunodeficiency virus type 1 subtype A virus circulating in West Africa: sub-subtype A3. Journal of Virology. 78: 12438-45. PMID 15507630 DOI: 10.1128/Jvi.78.22.12438-12445.2004 |
0.63 |
|
| Show low-probability matches. |